Compound Summary
药名: | tetrodotoxin |
分子式: | C11H17N3O8 |
Smiles: | C(C1(C2C3C(N=C(NC34C(C1OC(C4O)(O2)O)O)N)O)O)O |
成分: | HBIN046126 |
TCMID_id: | 21195 |
PubChem_id: | 139251219 |
DrugBank_id: | DB05232 |
植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
---|
TCMBANKHE007959 | Fugu ocellatus | 河豚 | To supplement liver and kidney, dispel damp and relieve pain./Impotence, enuresis, dizziness, limp aching lumbus and knees, wind-damp impediment pain, itchy skin. |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
TCMBANKDI000002 | Hyperalgesia | phenotype | Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 27013358 |
TCMBANKDI000004 | Chronic pain | phenotype | Pathological Conditions, Signs and Symptoms | 30648289 |
TCMBANKDI000021 | Stress, Psychological | disease | Behavior and Behavior Mechanisms | 27013358 |
TCMBANKDI000056 | Heart failure | disease | Cardiovascular Diseases | 25424392 |
TCMBANKDI000093 | Sepsis | disease | Pathological Conditions, Signs and Symptoms; Infections | 24669759 |
TCMBANKDI000095 | Pain | phenotype | Pathological Conditions, Signs and Symptoms | 30765606 |
TCMBANKDI000921 | Blood Pressure | phenotype | - | 23570977 |
TCMBANKDI005044 | Ventricular Remodeling | phenotype | Pathological Conditions, Signs and Symptoms | 29097069 |
TCMBANKDI011475 | Status Epilepticus | disease | Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 28860087 |
TCMBANKDI011774 | Brain Waves | phenotype | - | 30228120 |
TCMBANKDI012645 | Myotonia Congenita | disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases | 28833464 |
TCMBANKDI014716 | Epilepsy, Temporal Lobe | disease | Nervous System Diseases | 28860087 |
TCMBANKDI015485 | Schizophrenia | disease | Mental Disorders | 26819276 |
TCMBANKDI015830 | Myocardial Ischemia | disease | Cardiovascular Diseases | 29509584 |
TCMBANKDI016616 | Interstitial Cystitis | disease | Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 30157135 |
TCMBANKDI018581 | Gliosis | phenotype | Pathological Conditions, Signs and Symptoms | 24740847 |
TCMBANKDI020247 | Cardiomegaly | phenotype | Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 23570977 |
TCMBANKDI021084 | Bladder pain syndrome | disease | - | 30157135 |
TCMBANKDI023555 | Hypoxia | phenotype | Pathological Conditions, Signs and Symptoms | 27383588 |
TCMBANKDI029054 | Neurodevelopmental Disorders | group | Mental Disorders | 26819276 |
TCMBANKDI030645 | Photophobia | phenotype | Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases | 26086898 |
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE000054 | GAD1 | CPSQ1; GAD; SCP | glutamate decarboxylase 1 |
TCMBANKGE000055 | Ntf5 | 2900040K06Rik; AI462899; NT-4; NT-5; NT4; NT4/5; Ntf-5; Ntf4 | neurotrophin 5 |
TCMBANKGE000056 | SLC8B1 | NCKX6; NCLX; SLC24A6 | solute carrier family 8 member B1 |
TCMBANKGE000057 | MCU | C10orf42; CCDC109A; HsMCU | mitochondrial calcium uniporter |
TCMBANKGE000058 | SCN4A | CMS16; HOKPP2; HYKPP; HYPP; NAC1A; Na(V)1.4; Nav1.4; SkM1 | sodium voltage-gated channel alpha subunit 4 |
TCMBANKGE000059 | NGFR | CD271; Gp80-LNGFR; TNFRSF16; p75(NTR); p75NTR | nerve growth factor receptor |
TCMBANKGE000060 | CRHR1 | CRF-R; CRF-R-1; CRF-R1; CRF1; CRFR-1; CRFR1; CRH-R-1; CRH-R1; CRHR; CRHR1L | corticotropin releasing hormone receptor 1 |
TCMBANKGE000061 | OXTR | OT-R | oxytocin receptor |
TCMBANKGE000062 | SCN1A | EIEE6; FEB3; FEB3A; FHM3; GEFSP2; HBSCI; NAC1; Nav1.1; SCN1; SMEI | sodium voltage-gated channel alpha subunit 1 |
TCMBANKGE000063 | SCN8A | BFIS5; CERIII; CIAT; EIEE13; MED; MYOCL2; NaCh6; Nav1.6; PN4 | sodium voltage-gated channel alpha subunit 8 |
TCMBANKGE000064 | SCN3A | EIEE62; FFEVF4; NAC3; Nav1.3 | sodium voltage-gated channel alpha subunit 3 |
TCMBANKGE000065 | SCN9A | ETHA; FEB3B; GEFSP7; HSAN2D; NE-NA; NENA; Nav1.7; PN1; SFNP | sodium voltage-gated channel alpha subunit 9 |
TCMBANKGE000106 | SCN10A | FEPS2; Nav1.8; PN3; SNS; hPN3 | sodium voltage-gated channel alpha subunit 10 |
TCMBANKGE000171 | DNMT1 | ADCADN; AIM; CXXC9; DNMT; HSN1E; MCMT; m.HsaI | DNA methyltransferase 1 |
TCMBANKGE000224 | AGT | ANHU; SERPINA8; hFLT1 | angiotensinogen |
TCMBANKGE000235 | NTRK2 | EIEE58; GP145-TrkB; OBHD; TRKB; trk-B | neurotrophic receptor tyrosine kinase 2 |
TCMBANKGE000236 | BDNF | ANON2; BULN2 | brain derived neurotrophic factor |
TCMBANKGE000237 | CAMK2G | CAMK; CAMK-II; CAMKG; MRD59 | calcium/calmodulin dependent protein kinase II gamma |
TCMBANKGE000309 | SCN5A | CDCD2; CMD1E; CMPD2; HB1; HB2; HBBD; HH1; ICCD; IVF; LQT3; Nav1.5; PFHB1; SSS1; VF1 | sodium voltage-gated channel alpha subunit 5 |
TCMBANKGE000356 | SLC12A2 | BSC; BSC2; NKCC1; PPP1R141 | solute carrier family 12 member 2 |
TCMBANKGE000985 | GABRG1 | - | gamma-aminobutyric acid type A receptor subunit gamma1 |
TCMBANKGE000997 | GCG | GLP-1; GLP1; GLP2; GRPP | glucagon |